Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Capizzi

Showing results (1-10 of 495) with videos related to

Pageof 50
Sort By:
Seminars in Oncology|August 1, 1996
Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapiesR Capizzi
Cancer Treatment Reports|January 1, 1981
Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cellsR L Capizzi
Transactions of the American Clinical and Climatological Association|October 25, 2006
Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomasRobert L Capizzi
Seminars in Oncology|May 29, 1999
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostineR L Capizzi
Seminars in Oncology|May 29, 1999
Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspectsR L Capizzi
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol)R L Capizzi
Investigational New Drugs|January 1, 1996
Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedsideR L Capizzi
Oncology (Williston Park, N.Y.)|February 23, 1999
Clinical status and optimal use of amifostineR L Capizzi
Seminars in Oncology|October 1, 1994
Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (Ethyol): clinical experiencesR L Capizzi
Colloids and Surfaces. B, Biointerfaces|July 14, 2001
Surface properties of Ascaris suum eggs: hydrophobic potential and Lewis acid-base interactionsS Capizzi, J Schwartzbrod
Pageof 50

Showing results (1-10 of 495) with videos related to

Sort By:
Pageof 50
Seminars in Oncology|August 1, 1996
Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapiesR Capizzi
Cancer Treatment Reports|January 1, 1981
Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cellsR L Capizzi
Transactions of the American Clinical and Climatological Association|October 25, 2006
Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomasRobert L Capizzi
Seminars in Oncology|May 29, 1999
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostineR L Capizzi
Seminars in Oncology|May 29, 1999
Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspectsR L Capizzi
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol)R L Capizzi
Investigational New Drugs|January 1, 1996
Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedsideR L Capizzi
Oncology (Williston Park, N.Y.)|February 23, 1999
Clinical status and optimal use of amifostineR L Capizzi
Seminars in Oncology|October 1, 1994
Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (Ethyol): clinical experiencesR L Capizzi
Colloids and Surfaces. B, Biointerfaces|July 14, 2001
Surface properties of Ascaris suum eggs: hydrophobic potential and Lewis acid-base interactionsS Capizzi, J Schwartzbrod
Pageof 50